During the past decade, Wisconsin Heart Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wisconsin Heart Hospital" #1 collaborator was "Massachusetts General Hospital" with 1 trials as a collaborator and "Prairie Education and Research Cooperative" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wisconsin Heart Hospital" are "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials), "Known CAD, or Intermediate-high Pretest Likelihood for CAD" (1 trials), "PAD" (1 trials) and "Peripheral Artery Disease" (1 trials). Many other conditions were trialed in "Wisconsin Heart Hospital" in a lesser frequency.

Most popular intervention types in "Wisconsin Heart Hospital" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Flex 4 and Generator" (1 trials) and "FlexStent® Femoropopliteal Self Expanding Stent System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wisconsin Heart Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Wisconsin Heart Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Wisconsin Heart Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wisconsin Heart Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".